Assessing Denka (TSE:4061) Valuation After Earnings Show Stronger Profitability Despite Softer Sales

Denka (TSE:4061) recently reported nine-month earnings to December 31, 2025, with sales of ¥290,774 million, net income of ¥5,535 million, and basic EPS from continuing operations of ¥64.23. See our latest analysis for Denka. The earnings update appears to have supported sentiment, with a 90 day share price return of 30.86% and a 1 year total shareholder return of 54.00% suggesting momentum has picked up after a softer 30 day share price move. If Denka’s move has you thinking about where else strong performance might emerge, this could be a good moment to scan our 12 top founder-led companies and see what stands out. With earnings per share up year on year and the share price already strong, the key question now is whether Denka still trades at a discount or if the market is already pricing in further improvement. Preferred Price-to-Sales of 0.7x: Is it justified? On the latest figures, Denka trades on a P/S of 0.7x, which lines up with the broader JP Chemicals industry average of 0.7x, even after the strong share price run to ¥3,098. The P/S multiple compares the company’s market value with its annual revenue. It is a useful yardstick when earnings are volatile or, as here, when the company is currently loss making. For Denka, it helps you weigh the current revenue base against what the market seems willing to pay for each ¥ of sales. Relative to the sector, that 0.7x looks in line rather than stretched, yet it still sits a bit above the peer group average of 0.6x. At the same time, our estimated fair P/S of 0.8x suggests the current level could move closer to that higher mark if the market eventually prices Denka closer to this fair ratio benchmark. Explore the SWS fair ratio for Denka Result: Price-to-Sales of 0.7x (ABOUT RIGHT) However, there are still clear risks, including Denka’s recent net income loss of ¥9,342 million and a 5 year total return decline of 9.16% that might cap enthusiasm. Find out about the key risks to this Denka narrative. Another view on value: DCF points the other way There is a different signal coming from our DCF model. On this approach, Denka at ¥3,098 is trading above an estimated future cash flow value of ¥1,215.54, which suggests the shares screen as expensive rather than cheap. If sales multiples indicate “about right” but cash flows indicate “too rich”, which side do you lean toward? Look into how the SWS DCF model arrives at its fair value. 4061 Discounted Cash Flow as at Feb 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Denka for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 19 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps If this mix of signals leaves you on the fence, take a moment now to review the full picture for yourself, including 1 key reward and 2 important warning signs. Looking for more investment ideas? If you are weighing your next move, it is worth lining up a few fresh watchlist candidates so you are ready when conditions change again. Spot potential higher yield opportunities by scanning companies in our 12 dividend fortresses that may offer stronger income profiles than what you currently hold. Strengthen your core holdings by reviewing businesses in the solid balance sheet and fundamentals stocks screener (35 results) that pair financial resilience with steady fundamentals. Get ahead of the crowd by checking our screener containing 62 high quality undiscovered gems before these names appear on everyone else’s radar. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for Free